Overlap between EEC and AEC syndrome and immunodeficiency in a preterm infant with a TP63 variant.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
May 2023
Historique:
received: 03 06 2022
revised: 06 02 2023
accepted: 27 02 2023
medline: 3 4 2023
pubmed: 3 3 2023
entrez: 2 3 2023
Statut: ppublish

Résumé

Pathogenic variants in the transcription factor TP63 gene cause a variety of clinical phenotypes, such as ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome and ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome. Historically, TP63-related phenotypes have been divided into several syndromes based on both the clinical presentation and location of the pathogenic variant on the TP63 gene. This division is complicated by significant overlap between syndromes. Here we describe a patient with clinical characteristics of different TP63-associated syndromes (cleft lip and palate, split feet, ectropion, erosions of the skin and corneas), associated with a de novo heterozygous pathogenic variant c.1681 T>C, p.(Cys561Arg) in exon 13 of the TP63 gene. Our patient also developed enlargement of the left-sided cardiac compartments and secondary mitral insufficiency, which is a novel finding, and immune deficiency, which has only rarely been reported. The clinical course was further complicated by prematurity and very low birth weight. We illustrate the overlapping features of EEC and AEC syndrome and multidisciplinary care needed to address the various clinical challenges.

Identifiants

pubmed: 36863510
pii: S1769-7212(23)00041-1
doi: 10.1016/j.ejmg.2023.104735
pii:
doi:

Substances chimiques

Transcription Factors 0
TP63 protein, human 0
Tumor Suppressor Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104735

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Kjell Helenius (K)

Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland. Electronic address: kkhele@utu.fi.

Liisa Ojala (L)

Department of Ophthalmology, Turku University Hospital, Turku, Finland.

Leena Kainulainen (L)

Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Sirkku Peltonen (S)

Department of Dermatology, Turku University Hospital and University of Turku, Turku, Finland; Department of Dermatology and Venereology, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.

Marja Hietala (M)

Department of Genomics and Clinical Genetics, Turku University Hospital, Turku, Finland.

Pia Pohjola (P)

Department of Genomics and Clinical Genetics, Turku University Hospital, Turku, Finland.

Vilhelmiina Parikka (V)

Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH